Organon & Co.
OGN
$8.44
-$0.27-3.10%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.51B | 1.59B | 1.58B | 1.61B | 1.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.51B | 1.59B | 1.58B | 1.61B | 1.62B |
| Cost of Revenue | 672.00M | 696.00M | 659.00M | 668.00M | 665.00M |
| Gross Profit | 841.00M | 896.00M | 923.00M | 939.00M | 957.00M |
| SG&A Expenses | 420.00M | 468.00M | 422.00M | 437.00M | 431.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.19B | 1.29B | 1.19B | 1.22B | 1.21B |
| Operating Income | 325.00M | 298.00M | 390.00M | 386.00M | 414.00M |
| Income Before Tax | 101.00M | 129.00M | 207.00M | 235.00M | 236.00M |
| Income Tax Expenses | 14.00M | 20.00M | -152.00M | 40.00M | 35.00M |
| Earnings from Continuing Operations | 87.00M | 109.00M | 359.00M | 195.00M | 201.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.00M | 109.00M | 359.00M | 195.00M | 201.00M |
| EBIT | 325.00M | 298.00M | 390.00M | 386.00M | 414.00M |
| EBITDA | 409.00M | 375.00M | 459.00M | 452.00M | 479.00M |
| EPS Basic | 0.34 | 0.42 | 1.39 | 0.76 | 0.79 |
| Normalized Basic EPS | 0.49 | 0.36 | 0.63 | 0.61 | 0.67 |
| EPS Diluted | 0.33 | 0.41 | 1.38 | 0.75 | 0.78 |
| Normalized Diluted EPS | 0.49 | 0.36 | 0.62 | 0.60 | 0.66 |
| Average Basic Shares Outstanding | 257.86M | 257.69M | 257.50M | 257.29M | 255.70M |
| Average Diluted Shares Outstanding | 261.00M | 259.88M | 259.76M | 258.60M | 258.36M |
| Dividend Per Share | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
| Payout Ratio | 81.61% | 67.89% | 20.61% | 40.51% | 34.83% |